BTG plc (BTG) Given Buy Rating at Deutsche Bank AG
Several other research firms have also weighed in on BTG. Numis Securities Ltd reiterated a hold rating and issued a GBX 737 ($9.62) target price on shares of BTG plc in a report on Thursday, July 14th. Stifel Nicolaus lowered shares of BTG plc to a hold rating in a report on Thursday, July 14th. JPMorgan Chase & Co. upped their price objective on shares of BTG plc from GBX 790 ($10.31) to GBX 830 ($10.83) and gave the stock a neutral rating in a report on Friday. Finally, Jefferies Group upped their price objective on shares of BTG plc from GBX 840 ($10.96) to GBX 860 ($11.23) and gave the stock a buy rating in a report on Wednesday, June 29th. Three investment analysts have rated the stock with a hold rating and four have given a buy rating to the stock. BTG plc presently has an average rating of Buy and a consensus target price of GBX 799.57 ($10.44).
Shares of BTG plc (LON:BTG) traded down 0.43% during midday trading on Friday, reaching GBX 698.50. 304,086 shares of the company’s stock traded hands. The firm’s 50-day moving average price is GBX 629.82 and its 200 day moving average price is GBX 641.22. The stock’s market capitalization is GBX 2.67 billion. BTG plc has a 1-year low of GBX 504.00 and a 1-year high of GBX 739.50.
In related news, insider Soderstrom,Rolf sold 74,327 shares of the company’s stock in a transaction that occurred on Thursday, July 21st. The shares were sold at an average price of GBX 676 ($8.82), for a total transaction of £502,450.52 ($655,855.01).
BTG plc Company Profile
BTG plc is engaged in the business of healthcare, focusing on Interventional Medicine therapies for liver cancer, emphysema and vascular disorders, specialty pharmaceuticals for acute care uses, and a licensing business. The Company operates through three segments: Interventional Medicine, Specialty Pharmaceuticals and Licensing.
Receive News & Stock Ratings for BTG plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BTG plc and related stocks with our FREE daily email newsletter.